share_log

太龙药业(600222.SH):公司目前日常生产经营活动一切正常

Tailong Pharmaceutical (600222.SH): The company's current daily production and operation activities are all normal

Gelonghui Finance ·  Nov 8, 2023 03:46

Gelonghui November 8 | Tailong Pharmaceutical (600222.SH) announced that the company's stock closed for three consecutive trading days on November 6, November 7, and November 8, 2023, with a cumulative deviation value of more than 20%. According to the relevant provisions of the “Shanghai Stock Exchange Trading Rules”, this is an abnormal fluctuation in stock trading. In the first three quarters of 2023, the company achieved operating income of 1,443 billion yuan, net profit attributable to shareholders of listed companies - 16.926,400 yuan, and net profit attributable to shareholders of listed companies - 23.8875 million yuan after deducting non-recurring profits and losses. It is still in a state of loss. After self-inspection, the company's current daily production and operation activities are normal, and there have been no major adjustments in the market environment or industry policies.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment